Delphia (USA)’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-3,670
Closed -$249K 253
2023
Q1
$249K Sell
3,670
-4,032
-52% -$259K 0.3% 153
2022
Q4
$381K Sell
7,702
-1,293
-14% -$52.8K 0.44% 81
2022
Q3
$292K Buy
8,995
+996
+12% +$41.1K 0.33% 121
2022
Q2
$315K Buy
7,999
+2,392
+43% +$128K 0.22% 168
2022
Q1
$392K Buy
5,607
+2,213
+65% +$162K 0.29% 118
2021
Q4
$264K Buy
+3,394
New +$300K 0.28% 141

Other funds holding EXAS

Delphia (USA)'s EXAS Position: Q2 2023 in Review

Delphia (USA) sold out of Exact Sciences (EXAS) in Q2 2023, closing a stake of 3,670 shares — an estimated $249K sold.

Delphia (USA) first reported a position in EXAS in Q4 2021 and held it in 6 quarters. The position peaked at $392K in Q1 2022. 653 funds tracked by Wall St. Rank hold EXAS as of Q2 2023.

  • Delphia (USA) reported no remaining Exact Sciences position as of Q2 2023 after selling out during the quarter.
  • Delphia (USA) sold 3,670 Exact Sciences shares in Q2 2023, an estimated $249K.
  • Delphia (USA) first reported a position in Exact Sciences in Q4 2021 and held it in 6 quarters.
  • Delphia (USA)'s Exact Sciences position peaked at $392K in Q1 2022.
  • 653 funds tracked by Wall St. Rank held Exact Sciences as of Q2 2023.

Based on Delphia (USA)'s 13F filing for Q2 2023, filed 14 Aug 2023.